TY - DATA T1 - Additional files 6: Figure S6. of Increased tauopathy drives microglia-mediated clearance of beta-amyloid PY - 2016/06/23 AU - Wesley Chen AU - Edsel Abud AU - Stephen Yeung AU - Anita Lakatos AU - Trevor Nassi AU - Jane Wang AU - David Blum AU - Luc Buée AU - Wayne Poon AU - Mathew Blurton-Jones UR - https://springernature.figshare.com/articles/journal_contribution/Additional_files_6_Figure_S6_of_Increased_tauopathy_drives_microglia-mediated_clearance_of_beta-amyloid/4426100 DO - 10.6084/m9.figshare.c.3631799_D4.v1 L4 - https://ndownloader.figshare.com/files/7152740 KW - Amyloid KW - Aβ KW - Tau KW - Mice KW - Phagocytosis KW - Cytokines KW - Microglia KW - Pathology N2 - The combination of Aβ and Tau pathology leads to reductions in hippocampal β3-tubulin. (A-D) To determine whether T5x mice begin to exhibit early signs of neurodegeneration, dendritic architecture was examined by β3-tubulin immunolabeling of all four genotypes. (E-G) Quantification of β3-tubulin revealed a significant reduction in T5x mice compared to WT and transgenic littermates within the pyramidal cell layer (E; p < 0.05), stratum radiatum (F; p < 0.05), and molecular layer (G; WT, Tau p < 0.05; 5x p = 0.27) of the hippocampus. Data are represented as mean ± SEM of optical density (O.D.), n ≥ 8 mice/group. * Indicates p < 0.05 for both ANOVA and Fisher’s protected least-significant difference (PLSD) post hoc tests with significance versus all other groups, whereas *over a bar indicates significance between 2 or 3 particular groups. Scale Bar = 100 μm in A-D, 30 μm in H-J, and 10 μm in K. (PDF 3896 kb) ER -